Provided by Tiger Fintech (Singapore) Pte. Ltd.

ASCENTAGE-B

42.900
+5.75015.48%
Volume:7.29M
Turnover:301.43M
Market Cap:14.94B
PE:-30.15
High:43.100
Open:38.150
Low:38.150
Close:37.150
Loading ...

Ascentage Pharma ADSs to Begin Trading on Nasdaq

Dow Jones
·
24 Jan

Takeda-backed Ascentage Pharma aims to raise $126 mln in US IPO

Reuters
·
24 Jan

BRIEF-Ascentage Pharma Announces Pricing Of U.S. Initial Public Offering

Reuters
·
24 Jan

Ascentage Pharma Group International: to Begin Trading on Nasdaq Under Ticker Symbol "Aapg" for "Regular-Way" Trading

THOMSON REUTERS
·
24 Jan

Ascentage Pharma Announces Pricing of U.S. Initial Public Offering

THOMSON REUTERS
·
24 Jan

Stock Track | Ascentage Pharma Soars 12.27% on U.S. IPO Plans, Poised for Best Session in Nearly 5 Months

Stock Track
·
22 Jan

BUZZ-HK-listed Ascentage set for best day in near 5 months on US listing plan

Reuters
·
22 Jan

Takeda-backed Ascentage Pharma targets $1.75 bln valuation in US IPO

Reuters
·
21 Jan

China's Ascentage Pharma targets $149 mln raise in US IPO

Reuters
·
21 Jan

Ascentage Pharma Group International Sees US IPO of up to 7.3 Mln Adss - SEC Filing

THOMSON REUTERS
·
21 Jan

Ascentage Pharma Group International Files for Proposed US IPO

MT Newswires Live
·
30 Dec 2024

BRIEF-Ascentage Pharma Group International Files For U.S. IPO

Reuters
·
28 Dec 2024

Ascentage Pharma Group International Files for U.S. IPO – SEC Filing

THOMSON REUTERS
·
28 Dec 2024

Ascentage Pharma Group International: Applied to List Adss on Nasdaq, Under Symbol “Aapg"

THOMSON REUTERS
·
28 Dec 2024

Ascentage Pharma Group International Says Takeda Pharmaceuticals International Ag Beneficially Owned 7.7% of Ordinary Shares Prior to Offering

THOMSON REUTERS
·
28 Dec 2024

What Ascentage Pharma Group International's (HKG:6855) P/S Is Not Telling You

Simply Wall St.
·
23 Dec 2024

New Indication of Olverembatinib Included Into China 2024 National Reimbursement Drug List

THOMSON REUTERS
·
28 Nov 2024

Ascentage Pharma Group International's (HKG:6855) largest shareholders are individual investors who were rewarded as market cap surged HK$542m last week

Simply Wall St.
·
26 Nov 2024

Press Release: Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive Directors

Dow Jones
·
25 Nov 2024

Ascentage Pharma Announces a New Drug Application for Its Novel Bcl-2 Inhibitor Lisaftoclax Accepted and Recommended Priority Review Designation by Cde of China Nmpa

THOMSON REUTERS
·
17 Nov 2024